secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001654954-25-000919
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv FY2024 rev $9.5M (-$7.5M YoY), net loss $0.8M; declares $0.075 special dividend
--------------------------------------------------------------------------------

- Revenue for year ended Oct 31, 2024 approximately $9.5M, a decrease of $7.5M from prior year.
- Net loss of approximately $0.8M compared to net income of $1.3M in the prior year.
- Board approved a Special Dividend of $0.075 per share payable on or about March 20, 2025.
- CEO cited challenging industry conditions in 2024; focused on higher-value services and new technologies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425000919/0001654954-25-000919-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425000919/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-000919

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer